TrialCancer medicine2014

A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.

Gordan Srkalovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.